GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Gate AG (XTER:BIG1) » Definitions » Deferred Policy Acquisition Costs

Bio-Gate AG (XTER:BIG1) Deferred Policy Acquisition Costs


View and export this data going back to 2006. Start your Free Trial

What is Bio-Gate AG Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Bio-Gate AG (XTER:BIG1) Business Description

Traded in Other Exchanges
Address
Neumeyerstraße 28-34, Nürnberg, DEU
Bio-Gate AG is a Germany based medical technology company. The company employs silver technology to endow materials and products with antimicrobial properties. It is focused on the medical technology products portfolio. In addition, its technologies are also used to refine cosmetics, consumer goods, and industrial products. The products of the company are plasma-coating, additives, textile solutions, spray, masterbatches, and others. The organization uses two different technologies; first, silver particles are incorporated into cosmetics, paints, veneers or plastics, and second involve coating final products like implants or wound dressings with a silver-containing functional layer.
Executives
Karl Richter Supervisory Board